Literature DB >> 26188973

Analysis of Unexpected Conversion to Thoracotomy During Thoracoscopic Lobectomy in Lung Cancer.

Chun Sung Byun1, Sungsoo Lee2, Dae Joon Kim3, Jin Gu Lee3, Chang Young Lee3, Inkyung Jung4, Kyung Young Chung5.   

Abstract

BACKGROUND: Since anatomical lung resection by video-assisted thoracoscopic surgery (VATS) was first introduced, VATS has played a major role in lung cancer. However, conversion to thoracotomy is a major concern because an unexpected thoracotomy increases the risk of potentially adverse outcomes. Therefore, we compared patients who were and were not converted to thoracotomy and identified the risk factors for thoracotomy conversion.
METHODS: Between January 2005 and December 2013, 69 of 1,110 VATS lobectomies for lung cancer required an unexpected conversion to thoracotomy. Each converted patient was individually matched to 3 randomly selected nonconverted patients based on date of operation, type of operation, and pathologic stage.
RESULTS: The most common cause of conversion was fibrocalcified lymph nodes, found in 28 patients (40.6%), followed by vascular injury in 20, tumor invasion or extension in 11, pleural adhesion in 5, incomplete interlobar fissure in 3, and failure of single-lung ventilation in 2. The differences in overall postoperative complications and in-hospital deaths were not significant; however, respiratory complications were significantly more common in the conversion group (p = 0.012). The independent risk factors for conversion were age 65 years and older, forced expiratory volume in 1 second of less than 1.8 L, and the presence of fibrocalcified lymph nodes on preoperative chest computed tomography.
CONCLUSIONS: Unexpected conversion to thoracotomy during VATS lobectomy in lung cancer does not appear to increase overall surgical morbidity and mortality. However, with high-risk patients, the surgeon requires careful selection for VATS candidate. Also, if necessary, the decision to convert must be made promptly to reduce possible critical respiratory complications.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26188973     DOI: 10.1016/j.athoracsur.2015.04.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  26 in total

1.  Troubleshooting complicated hilar anatomy via prophylactically clamping the pulmonary artery: three videos demonstrating three techniques.

Authors:  Chengwu Liu; Lin Ma; Qiang Pu; Jiandong Mei; Hu Liao; Yunke Zhu; Feng Lin; Lunxu Liu
Journal:  Ann Transl Med       Date:  2018-09

2.  How to deal with benign hilar or interlobar lymphadenopathy during video-assisted thoracoscopic surgery lobectomy-firing the bronchus and pulmonary artery together.

Authors:  Chengwu Liu; Lin Ma; Qiang Pu; Hu Liao; Lunxu Liu
Journal:  J Vis Surg       Date:  2016-02-23

3.  Is Calcification in the Regional Lymph Nodes a Benign Feature in Patients with Lung Cancer?

Authors:  Keita Nakanishi; Kazuo Nakagawa; Keisuke Asakura; Yukihiro Yoshida; Hirokazu Watanabe; Shun-Ichi Watanabe
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

4.  Predictors of conversion to thoracotomy during video-assisted thoracoscopic surgery lobectomy in lung cancer: additional predictive value of FDG-PET/CT in a tuberculosis endemic region.

Authors:  Chun Geun Lim; Kyung Min Shin; Ji Seun Lim; Jae Kwang Lim; Hye Jung Kim; Won Hwa Kim; Seung Hyun Cho; Seung Ick Cha; Eung Bae Lee; Yangki Seock; Shin Young Jeong
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

5.  Body surface area: a novel predictor for conversion to thoracotomy in patients undergoing video-assisted thoracoscopic lung cancer lobectomy.

Authors:  Shuang-Jiang Li; Kun Zhou; Cheng Shen; Peng-Fei Li; Yan-Ming Wu; Zhi-Qiang Wang; Guo-Wei Che
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database.

Authors:  Stefano Bongiolatti; Alessandro Gonfiotti; Domenico Viggiano; Sara Borgianni; Leonardo Politi; Roberto Crisci; Carlo Curcio; Luca Voltolini
Journal:  Surg Endosc       Date:  2019-01-31       Impact factor: 4.584

7.  The evolution of intraoperative conversion in video assisted thoracoscopic lobectomy.

Authors:  A Vallance; P Tcherveniakov; C Bogdan; N Chaudhuri; R Milton; E Kefaloyannis
Journal:  Ann R Coll Surg Engl       Date:  2016-08-09       Impact factor: 1.891

8.  How to deal with benign hilar or interlobar lymphadenopathy during video-assisted thoracoscopic surgery lobectomy.

Authors:  Shi Yan; Chao Lv; Xing Wang; Nan Wu
Journal:  J Vis Surg       Date:  2016-02-26

9.  Two cases of combined thoracoscopy and open chest surgery for locally advanced lung carcinoma.

Authors:  Hitoshi Dejima; Hiroaki Kuroda; Katsutoshi Seto; Shozo Sakata; Takaaki Arimura; Tetsuya Mizuno; Noriaki Sakakura; Yukinori Sakao
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 10.  International expert consensus on the management of bleeding during VATS lung surgery.

Authors:  Lunxu Liu; Jiandong Mei; Jie He; Todd L Demmy; Shugeng Gao; Shanqing Li; Jianxing He; Yang Liu; Yunchao Huang; Shidong Xu; Jian Hu; Liang Chen; Yuming Zhu; Qingquan Luo; Weimin Mao; Qunyou Tan; Chun Chen; Xiaofei Li; Zhu Zhang; Gening Jiang; Lin Xu; Lanjun Zhang; Jianhua Fu; Hui Li; Qun Wang; Deruo Liu; Lijie Tan; Qinghua Zhou; Xiangning Fu; Zhongmin Jiang; Haiquan Chen; Wentao Fang; Xun Zhang; Yin Li; Ti Tong; Zhentao Yu; Yongyu Liu; Xiuyi Zhi; Tiansheng Yan; Xingyi Zhang; Qiang Pu; Guowei Che; Yidan Lin; Lin Ma; Raul Embun; Javier Aragón; Serdar Evman; Gregor J Kocher; Luca Bertolaccini; Alessandro Brunelli; Diego Gonzalez-Rivas; Joel Dunning; Hui-Ping Liu; Scott J Swanson; Ryabov Andrey Borisovich; Inderpal S Sarkaria; Alan Dart Loon Sihoe; Takeshi Nagayasu; Takuro Miyazaki; Masayuki Chida; Tadasu Kohno; Agasthian Thirugnanam; Harmic J Soukiasian; Mark W Onaitis; Chia-Chuan Liu
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.